Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs165857 | chr22:21205257 | A/G | 2.26E-6 | 170 | 25.4 | 31.2 | 12.57 | KM Plot |
PCPG | rs1677722 | chr10:26934152 | C/T | 0.000146 | 178 | 26.27 | 22.63 | 24.53 | KM Plot |
PCPG | rs1677724 | chr10:26932323 | A/G | 0.000146 | 177 | 26.57 | 22.63 | 24.53 | KM Plot |
PCPG | rs16823034 | chr1:36920810 | C/T | 7.31E-5 | 178 | 25.4 | 26.62 | 10.3 | KM Plot |
PCPG | rs16826787 | chr1:40511044 | A/G | 3.3E-6 | 170 | 25 | 25.53 | 37.18 | KM Plot |
PCPG | rs16826814 | chr1:40518110 | C/G | 0.000336 | 175 | 25 | 27.27 | 25.17 | KM Plot |
PCPG | rs16863112 | chr2:176146829 | C/T | 0.000139 | 175 | 25.28 | 28.47 | 6.62 | KM Plot |
PCPG | rs16863136 | chr2:176214049 | A/G | 0.000112 | 178 | 6.62 | 28.38 | 25.28 | KM Plot |
PCPG | rs16868144 | chr7:158846831 | C/T | 0.000194 | 176 | 25.53 | 19.87 | 41.87 | KM Plot |
PCPG | rs16870033 | chr8:104083786 | G/T | 7.93E-12 | 178 | 25.08 | 26.57 | 6.03 | KM Plot |
PCPG | rs16941185 | chr16:86443847 | C/T | 0.000222 | 178 | 25.17 | 30.18 | 3.17 | KM Plot |
PCPG | rs16941250 | chr16:86456876 | C/T | 0.000218 | 178 | 41.12 | 26.4 | 25.08 | KM Plot |
PCPG | rs16959447 | chr17:64512341 | A/G | 0.000257 | 178 | 25.17 | 29.43 | 24.6 | KM Plot |
PCPG | rs16969038 | chr15:39748389 | A/G | 0.000421 | 178 | 24.85 | 26.47 | 26.33 | KM Plot |
PCPG | rs16978577 | chr18:44146836 | A/G | 9.19E-8 | 178 | 25.17 | 26.53 | 19.87 | KM Plot |